1. Home
  2. ZLAB vs SCL Comparison

ZLAB vs SCL Comparison

Compare ZLAB & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$18.23

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Stepan Company

SCL

Stepan Company

HOLD

Current Price

$49.60

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
SCL
Founded
2013
1932
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.1B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ZLAB
SCL
Price
$18.23
$49.60
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$57.22
N/A
AVG Volume (30 Days)
832.3K
155.3K
Earning Date
02-26-2026
02-18-2026
Dividend Yield
N/A
3.21%
EPS Growth
N/A
N/A
EPS
N/A
1.98
Revenue
$441,629,000.00
$2,303,837,000.00
Revenue This Year
$26.16
$8.79
Revenue Next Year
$30.62
$8.14
P/E Ratio
N/A
$24.91
Revenue Growth
24.14
5.35
52 Week Low
$16.82
$41.82
52 Week High
$44.34
$65.89

Technical Indicators

Market Signals
Indicator
ZLAB
SCL
Relative Strength Index (RSI) 44.35 69.31
Support Level $17.18 $46.70
Resistance Level $17.97 $47.77
Average True Range (ATR) 0.60 1.06
MACD 0.28 0.04
Stochastic Oscillator 64.84 98.41

Price Performance

Historical Comparison
ZLAB
SCL

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Share on Social Networks: